Market Tracker

03/30 8:21am ET

Endocyte Inc (NASDAQ:ECYT)

2.42
Delayed Data
As of Mar 29
 +0.09 / +3.86%
Today’s Change
1.98
Today|||52-Week Range
4.33
-5.10%
Year-to-Date
5 Cheap Breakout Stocks for Superb Returns
Mar 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close2.33
Today’s open2.34
Day’s range2.31 - 2.46
Volume218,731
Average volume (3 months)227,459
Market cap$102.8M
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)-6.12%
Earnings growth (this year)-10.82%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,537.67
Price/Book0.75

Competitors

 Today’s
change
Today’s
% change
AFMDAffimed NV-0.10-4.08%
BDSIBioDelivery Sciences...0.000.00%
MSLIMerus Labs Internati...-0.01-0.96%
AGRXAgile Therapeutics I...+0.33+10.44%
Data as of 03/29/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$70.0K
Annual profit (last year)-$43.9M
Net profit margin-62,696.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Sherman
Chief Financial Officer
Michael T. Andriole
Corporate headquarters
West Lafayette, Indiana

Forecasts